NovoCure Company
Novocure™ is dedicated to the development of tumor treating fields therapy (NovoTTF™ Therapy), a new weapon for patients and physicians in the battle against cancer. NovoTTF Therapy is a novel anti-mitotic treatment that has been shown to slow or reverse tumor progression by inducing cell death in certain solid tumors. The company pioneered the concept that the electric properties of cells can be used as an effective target for an anti-neoplastic therapy.
%20.jpg)
Employee Number:
1001-5000
Headquarters:
Zug, Zug, Switzerland, Europe
Founded Date:
2000-01-01
Industry:
Monitoring & Wearable Medical Devices
Super Industry:
MedTech & Devices
Phone Number:
+1 603 436 2809
Investors:
Index Ventures, JP Morgan Chase, Pfizer, Pfizer Venture Investments, Pharmakon Advisors
Ipo Status:
public
Stock Symbol:
NVCR
City:
Zug
Region:
Zug
Country:
Switzerland
Founders:
William F. Doyle, Yoram Palti